Where does Arlanxeo Singapore PTE. Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Arlanxeo Singapore PTE. Ltd. ranks #10,254 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Arlanxeo Singapore PTE. Ltd. hold?

Arlanxeo Singapore PTE. Ltd. holds 30 US utility patents granted between 2016 and 2025, spanning 21 technology areas.

What is Arlanxeo Singapore PTE. Ltd.'s Innovation Score?

Arlanxeo Singapore PTE. Ltd. has an Innovation Score of 43.9 out of 100 (top 27% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Arlanxeo Singapore PTE. Ltd.'s patent grant rate increasing or decreasing?

Arlanxeo Singapore PTE. Ltd.'s recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Arlanxeo Singapore PTE. Ltd.'s patents?

Arlanxeo Singapore PTE. Ltd.'s patents average 18.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Arlanxeo Singapore PTE. Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Arlanxeo Singapore PTE. Ltd.

Q: What technology areas does Arlanxeo Singapore PTE. Ltd. focus on?

Arlanxeo Singapore PTE. Ltd.'s top technology area is C08F (Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds) with 21 patents, ranking #149 of 1,231 assignees active in that subclass. Grants appear in 21 CPC subclasses total.

USPTO PatentsView assignee record - 30 granted patents across 21 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08F (Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Arlanxeo ranks #10,254 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 21 technology areas.

#10,254
of 49,997 US assignees by volume: Top 27%
by Innovation Score (43.9/100): 18.7
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10254 · Foreign Corporation #10,254 · 30 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 30 grants
UPPER-Q #10,254/49,997
PHOTO-FINISH AcuFocus
CPC-FOCUS C08F · 21 areas
INNOV-PAR 43.9/100
CLAIMS-RICH 18.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: AcuFocus, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Arlanxeo’s 43.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.9 pts (27%) Velocity 4.6 pts (10%) Breadth 16.2 pts (37%) Claim depth 11.2 pts (26%)

Qualcomm Incorporated · highest

85
Arlanxeo Singapore PTE · this assignee

44
Finch Therapeutics… · near

44
PME IP PTY · near

44
Qingdao Haier Joint… · near

44
Rehabilitation… · near

44
3D Lighting… · lowest

7

What this shows Arlanxeo's Innovation Score is 43.9/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Arlanxeo?

Each dot is one of Arlanxeo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Arlanxeo’s own 18.7 claims/patent is ABOVE the 15.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Arlanxeo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Arlanxeo's grants concentrate

Arlanxeo Singapore PTE. Ltd. is a focused PatentsView assignee: 21 CPC subclasses with 70% of grants classified under C08F (Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds). Peak complete grant year is 2020 (7 grants) versus a trough of 1 in 2019. By volume, Arlanxeo sits between Amphenol-tuchel Electronics GMBH and AcuFocus, Inc..

Arlanxeo's three-year grant acceleration

Arlanxeo Singapore PTE. Ltd. shows 9 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Amphenol-tuchel

30
Amulaire Thermal…

30
Aputure Imaging I…

30
Ardisam

30
Ascentage Pharma…

30
Asus Technology L…

30
Azurewave

30
Acufocus

30
Arlanxeo Singapor… ◀

30

What this shows Arlanxeo holds 30 patents at rank #10,247, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Arlanxeo

By rank, the assignees closest to #10,247 in granted patent volume.

Leaders in C08F (Macromolecular Compounds Obtained BY Reactions Only Invol…)

Other assignees with the most granted patents in Arlanxeo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Arlanxeo, neither rank-band nor same-CPC leaders (those blocks stay above). In C08F (Macromolecular Compounds Obtained BY Reactions Only Invol…), Arlanxeo ranks #149 of 1,231 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Finch Therapeutics Holdings LLC 44 Rehabilitation Institute of Chicago 44 PME IP PTY Ltd 44 Qingdao Haier Joint Stock Co., Ltd. 44

Arlanxeo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Arlanxeo Singapore PTE. Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	6.7%
2018	4	13.3%
2019	1	3.3%
2020	7	23.3%
2021	5	16.7%
2022	3	10.0%
2023	3	10.0%
2024	3	10.0%
2025partial year	2	6.7%

Which technologies does Arlanxeo Singapore PTE. Ltd. patent most?

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 21

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 15

C08L - Compositions OF Macromolecular Compounds 15

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 11

C08C - Treatment OR Chemical Modification OF Rubbers 5

C09K - Materials FOR Miscellaneous Applications, NOT Provided FOR Elsewhere 4

F16J - Pistons ; CYLINDERS; Sealings 3

B29B - Preparation OR Pretreatment OF THE Material TO BE SHAPED; Making Granules OR PREFORMS; Recovery OF Plastics OR Other Constituents OF Waste Material Containing Plastics 2

Y10T - Technical Subjects Covered BY Former US Classification 2

C07C - Acyclic OR Carbocyclic Compounds 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

B81B - Microstructural Devices OR Systems, e.g. Micromechanical Devices 1

B81C - Processes OR Apparatus Specially Adapted FOR THE Manufacture OR Treatment OF Microstructural Devices OR Systems 1

G03F - Photomechanical Production OF Textured OR Patterned Surfaces, e.g. FOR Printing, FOR Processing OF Semiconductor DEVICES; Materials THEREFOR; Originals THEREFOR; Apparatus Specially Adapted THEREFOR; 1

B08B - Cleaning IN GENERAL; Prevention OF Fouling IN General 1

Top 15 of 21 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Arlanxeo Singapore PTE. Ltd.'s patent record in context - here's where to go next.

Arlanxeo Singapore PTE. Ltd.'s lead technology class is C08F (Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds), 70% of its portfolio - see every assignee active in that class. Explore C08F
Ranked #10,254 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Arlanxeo Singapore PTE. Ltd. against Amphenol-tuchel Electronics GMBH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.